Predicting Success in the Biotech and Pharma Sectors Mark Schoenebaum of ISI Group earned two top spots on this year's All-America Research Team. Here he explains how he differentiates the good stocks from the bad. Related Articles Emotional Yields and the Price of Feeling Good Christopher Schelling For Members Only Biopharma Continues to Buoy the IPO Market Stephen Taub High Beef Prices Test Consumers This Grilling Season Sponsored by CME Group